Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretin ePFT in Pediatric Abdominal Pain
NCT04231279Phase 3Terminated
- Start
- Jan 2022
- Primary completion
- Jun 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of secretin in exocrine pancreatic insufficiency (EPI). Started Jan 2022; status: terminated.
02
Drugs
secretin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT04231279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04231279.